Comments on systematic review of clinical- and cost-effectiveness of candesartan and losartan in hypertension and heart failure. [electronic resource]
Producer: 20111223Description: 911; author reply 912 p. digitalISSN:- 1742-1241
No physical items for this record
Publication Type: Letter; Comment
There are no comments on this title.
Log in to your account to post a comment.